Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,217,340 papers from all fields of science
Search
Sign In
Create Free Account
SK&F 59962
Known as:
SK&F-59962
, SKF 59962
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
cefazaflur
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
A New Parenteral Cephalosporin. SK&F 59962: Serum Levels and Urinary Recovery in Man
P. Actor
,
D. Pitkin
,
G. Lucyszyn
,
J. Weisbach
,
J. L. Bran
1976
Corpus ID: 67987980
The pharmacokinetic profile of SK&F 59962, a new parenteral cephalosporin, was found to be similar to that of cephalothin after…
Expand
1976
1976
Antistaphylococcal Activity and β-Lactamase Resistance of Newer Cephalosporins
Farrar We
,
P. K. Gramling
1976
Corpus ID: 73137653
Four newer cephalosporins (cefazolin, cefamandole, SK&F 59962, and cefoxitin) were investigated for determination of their…
Expand
1976
1976
Synthesis and in vitro antibacterial activity of 7-trifluoromethylthioacetamido cephamycins related to SK&F 59962 (cefazaflur).
R. Demarinis
,
J. Uri
,
J. Weisbach
Journal of antibiotics (Tokyo. )
1976
Corpus ID: 22550955
1976
1976
Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.
W. Farrar
,
P. K. Gramling
Journal of Infectious Diseases
1976
Corpus ID: 9477421
Four newer cephalosporins (cefazolin, cefamandole, SK&F 59962, and cefoxitin) were investigated for determination of their…
Expand
1975
1975
A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.
P. Actor
,
J. Uri
,
+6 authors
J. Weisbach
Journal of antibiotics (Tokyo. )
1975
Corpus ID: 37811419
SK&F 59962, a new parenteral cephalosporin was found to have a high order of in vitro and in vivo antibacterial activity against…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE